Miracor Medical
De berekende faillissementskans van Miracor Medical over 12 maanden bedraagt 0,2% (zeer laag). Het bedrijf is actief sinds 2017 en het Belgisch Staatsblad bevat geen insolventie- of waarschuwingssignalen. Er zijn geen verwerkte jaarrekeningcijfers beschikbaar; deze conclusie steunt uitsluitend op register- en Staatsbladgegevens.
| Actief | 8 jaar |
| Vestigingen | 1 |
| Publicaties | 23 |
Statistische inschatting op basis van openbare bronnen — geen kredietadvies of vaststelling. Hoe berekenen we dit?
| Boekjaar | Type | Neerlegging | Referentie |
|---|---|---|---|
| 31-12-2024 | volledig | 30-06-2025 | 2025-00242425 |
| 31-12-2023 | volledig | 10-07-2024 | 2024-00237802 |
| 31-12-2022 | volledig | 06-06-2023 | 2023-00126111 |
| 31-12-2021 | volledig | 07-07-2022 | 2022-20187532 |
| 31-12-2020 | volledig | 10-06-2021 | 2021-19000327 |
| 31-12-2019 | volledig | 25-06-2020 | 2020-22600239 |
| 31-12-2018 | volledig | 02-10-2019 | 2019-68000136 |
| NACE primair | 26600 |
| Rechtsvorm | NV(014) |
| Oprichtingsdatum | 28-07-2017 |
| Status | Actief |
| Postcode | 4340 |
Percelen gekoppeld aan dit bedrijf via zijn adressen in de KBO (zetel, vestigingen, bijkantoren), gekruist met het kadastraal percelenplan. Dit toont waar het bedrijf actief is — geen eigendomsregister.
| Perceel (capakey) | Regio | Oppervlakte | Gebouwen | Hoogte / verd. |
|---|---|---|---|---|
| 62006B0520/00Y000 | Wallonië | 6,1 ha | 1 · 2,8 ha | 12,6 m · 3 verd. |
Eén tijdlijn van alles wat er met dit bedrijf is gebeurd — publicaties, insolventie- en levensloopgebeurtenissen, administratieve wijzigingen en neergelegde jaarrekeningen.
01-09-2023 4 bestuurders benoemd, 5 ontslagnemend
- B&O Associates — Administrateur cfo
- ODMC — Administrateur ceo
- Thom RASCHE — Bestuurder
- WEMANITEC GmbH — Voorzitter
- ODMC — Bestuurder
- Life Science Strategy Consulting — Bestuurder
- Thom RASCHE — Bestuurder
- WEMANITEC GmbH — Bestuurder
Technische details
{
"events": [
{
"kind": "director_in",
"role": "Administrateur CFO",
"person": {
"rrn": null,
"name": "B\u0026O Associates",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "Administrateur CEO",
"person": {
"rrn": null,
"name": "ODMC",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "Administrateur",
"person": {
"rrn": null,
"name": "Thom RASCHE",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "Pr\u00E9sident",
"person": {
"rrn": null,
"name": "WEMANITEC GmbH",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "Administrateur",
"person": {
"rrn": null,
"name": "ODMC",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "Administrateur",
"person": {
"rrn": null,
"name": "Life Science Strategy Consulting",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "Administrateur",
"person": {
"rrn": null,
"name": "Thom RASCHE",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "Administrateur",
"person": {
"rrn": null,
"name": "WEMANITEC GmbH",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "Administrateur",
"person": {
"rrn": null,
"name": "Chong WANG",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0678.963.277",
"name_full": "Miracor Medical"
}
}01-09-2023 Statutenwijziging
Technische details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0678.963.277",
"name_full": "Miracor Medical"
},
"legal_form_change": {
"new": "Soci\u00E9t\u00E9 anonyme",
"old": "Soci\u00E9t\u00E9 anonyme",
"changed": false
}
}14-04-2023 Evan Castiglia neemt ontslag als bestuurder
- Evan Castiglia — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Evan Castiglia",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0678.963.277",
"name_full": "Miracor Medical"
}
}14-04-2023 Evan Castiglia neemt ontslag als bestuurder
- Evan Castiglia — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Evan Castiglia",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "de_plein_droit_dissolution",
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": "2023-03-31",
"evidence_quote": "Monsieur Evan Castiglia informe le Conseil d\u0027Administration de sa d\u00E9cision de d\u00E9missionner de son poste d\u0027administrateur \u00E0 dater du 31 mars 2023.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "Liege",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": null,
"filing_date": "2023-03-31",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "conseil_d_administration",
"date": "2023-03-15",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0678.963.277",
"name_full": "Miracor Medical",
"legal_form": "Soci\u00E9t\u00E9 anonyme"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "Allen \u0026 Overy (Belgium) LLP",
"person_name": null,
"org_rep_person_name": "Susana Gonzalez Melon",
"person_role_at_subject": null
},
"co_filed_documents": [
"Bijlagen bij het Belgi",
"xes du Moniteur belge",
"Voler B",
"Copie \u00E0 publier aux annexes au Moniteur belge",
"Mod DOC 19,01"
],
"corrected_publication_numac": null
}29-08-2022 Publicatie in het Belgisch Staatsblad — Diversen
Technische details
{
"stage": null,
"notary": {
"name": "Yorik DESMYTTERE",
"firm_city": null,
"firm_name": "BERQUIN NOTAIRES",
"office_city": "Bruxelles",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2022-08-29",
"filing_date": "2022-08-25",
"act_kind_objet": "DIVERS"
},
"decision": {
"body": "bijzondere_algemene_vergadering",
"act_date": "2022-08-18",
"unanimous": null
},
"conversion": null,
"detected_kind": "other",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0678.963.277",
"name": "Miracor Medical",
"role": "other",
"address": "E40 Business Park, rue de Bruxelles 174, 4340 Awans",
"is_foreign": false,
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": null,
"legal_articles": [
"7:155",
"7:180",
"7:191",
"43\u00A74"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": 642910,
"real_estate_included": false,
"patrimony_description": "\u00C9mission de 642.910 warrants donnant droit \u00E0 la souscription d\u0027une nouvelle action de classe A par warrant, sous condition suspensive d\u0027exercice. L\u0027augmentation de capital en num\u00E9raire est conditionnelle \u00E0 l\u0027exercice des warrants.",
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0678.963.277",
"name_full": "Miracor Medical",
"legal_form": "Soci\u00E9t\u00E9 anonyme"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Yorik DESMYTTERE",
"org_rep_person_name": null
},
"summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de Miracor Medical, r\u00E9unie le 18 ao\u00FBt 2022, a approuv\u00E9 l\u0027\u00E9mission de 642.910 warrants gratuits dans le cadre du Plan Warrants 2022, donnant droit \u00E0 la souscription d\u0027une action de classe A par warrant. L\u0027assembl\u00E9e a \u00E9galement approuv\u00E9 l\u0027augmentation de capital en num\u00E9raire conditionnelle \u00E0 l\u0027exercice des warrants, et a conf\u00E9r\u00E9 au conseil d\u0027administration tous les pouvoirs n\u00E9cessaires pour g\u00E9rer le plan et proc\u00E9der aux \u00E9missions et modifications statutaires.",
"co_filed_documents": [
"une exp\u00E9dition du proc\u00E8s-verbal",
"une liste de pr\u00E9sence",
"le Plan de Warrants 2022",
"le rapport du conseil d\u0027administration \u00E9tabli conform\u00E9ment \u00E0 l\u0027article 7 :155 du Code des soci\u00E9t\u00E9s et des associations",
"le rapport du conseil d\u0027administration \u00E9tabli conform\u00E9ment aux articles 7 :180 et 7 :191 du Code des soci\u00E9t\u00E9s et des associations et \u00E0 l\u0027article 43\u00A74 de la loi du 26 mars 1999 relative au plan d\u0027action belge pour l\u0027emploi",
"le rapport du commissaire \u00E9tabli conform\u00E9ment aux articles 7 :155, 7 :180 et 7 :191 du Code des soci\u00E9t\u00E9s et des associations",
"le rapport du commissaire \u00E9tabli conform\u00E9ment \u00E0 l\u0027article 43\u00A74 de la loi du 26 mars 1999 relative au plan d\u0027action belge pour l\u0027emploi",
"le texte coordonn\u00E9 des statuts"
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": "capital_shares"
}22-06-2021 EY Réviseurs d'Entreprises benoemd tot commissaire
- EY Réviseurs d'Entreprises — Commissaire
Technische details
{
"events": [
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "EY R\u00E9viseurs d\u0027Entreprises",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0678.963.277",
"name_full": "Miracor Medical"
}
}14-09-2020 12 bestuurders benoemd, 4 ontslagnemend
- la société à responsabilité limitée "ODMC" — Bestuurder
- la société à responsabilité limitée "Life Science Strategy Consulting" — Bestuurder
- Monsieur RASCHE Thom Eugen — Bestuurder
- la société à responsabilité limitée de droit allemand "WEMANITEC GmbH" — Bestuurder
- Monsieur WANG Chong — Bestuurder
- Monsieur CASTIGLIA Evan Michael — Bestuurder
- Monsieur DEGIVE Philippe — Observateur
- Zoll Medical Corporation — Observateur
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Monsieur MOHL Werner",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Monsieur KENNY Frank",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Zoll Medical Corporation",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Ming VitaMed",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u0022ODMC\u0022",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u0022Life Science Strategy Consulting\u0022",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Monsieur RASCHE Thom Eugen",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e de droit allemand \u0022WEMANITEC GmbH\u0022",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Monsieur WANG Chong",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Monsieur CASTIGLIA Evan Michael",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "observateur",
"person": {
"rrn": null,
"name": "Monsieur DEGIVE Philippe",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "observateur",
"person": {
"rrn": null,
"name": "Zoll Medical Corporation",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "observateur",
"person": {
"rrn": null,
"name": "Monsieur RICE Chad",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "observateur",
"person": {
"rrn": null,
"name": "Monsieur MOHL Werner",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "observateur",
"person": {
"rrn": null,
"name": "Monsieur KENNY Frank",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "observateur",
"person": {
"rrn": null,
"name": "Monsieur MAGNUS Holm",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0678.963.277",
"name_full": "Miracor Medical"
}
}14-09-2020 Kapitaalverhoging van €699.689,03 tot €1.620.847,40
- €921.158,37 → €1.620.847,40
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 1620847.4,
"delta_eur": 699689.0299999999,
"before_eur": 921158.37,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0678.963.277",
"name_full": "Miracor Medical"
}
}14-09-2020 Statutenwijziging
Technische details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0678.963.277",
"name_full": "Miracor Medical"
},
"legal_form_change": {
"new": "Soci\u00E9t\u00E9 anonyme",
"old": "Soci\u00E9t\u00E9 anonyme",
"changed": false
}
}16-12-2019 1 bestuurder benoemd, 1 ontslagnemend
- Bertrand Grimmonpré — Gestion journalière
- Patrick Burgermeister — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Patrick Burgermeister",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "Bertrand Grimmonpr\u00E9",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0678.963.277",
"name_full": "Miracor Medical"
}
}24-10-2019 Kapitaalverhoging van €2.625 tot €921.158,37
- €918.533,37 → €921.158,37
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 921158.37,
"delta_eur": 2625.0,
"before_eur": 918533.37,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0678.963.277",
"name_full": "Miracor Medical"
}
}01-10-2019 Wijziging in het bestuur
Technische details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0678.963.277",
"name_full": "Miracor Medical"
}
}04-03-2019 4 bestuurders benoemd, 1 ontslagnemend
- Olivier Delporte — Représentant de odmc bvba
- Anne Tilleux — Mandataire
- William Hollanders de Ouderaen — Mandataire
- Pierre Luttgens — Mandataire
- B&O Associates SPRL — Mandataire spécial
Technische details
{
"events": [
{
"kind": "director_out",
"role": "mandataire sp\u00E9cial",
"person": {
"rrn": null,
"name": "B\u0026O Associates SPRL",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "repr\u00E9sentant de ODMC BVBA",
"person": {
"rrn": null,
"name": "Olivier Delporte",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "mandataire",
"person": {
"rrn": null,
"name": "Anne Tilleux",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "mandataire",
"person": {
"rrn": null,
"name": "William Hollanders de Ouderaen",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "mandataire",
"person": {
"rrn": null,
"name": "Pierre Luttgens",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0678.963.277",
"name_full": "MIRACOR MEDICAL"
}
}09-08-2018 Kapitaalverhoging van €106.173,67 tot €918.533,37
- €812.359,70 → €918.533,37
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 918533.37,
"delta_eur": 106173.67000000004,
"before_eur": 812359.7,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0678.963.277",
"name_full": "Miracor Medical"
}
}18-05-2018 Publicatie in het Belgisch Staatsblad — Diversen
Technische details
{
"stage": null,
"notary": {
"name": "Peter VAN MELKEBEKE",
"firm_city": null,
"firm_name": "Berquin Notaires",
"office_city": "Bruxelles",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2018-05-18",
"filing_date": "2018-05-16",
"act_kind_objet": ""
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2018-05-04",
"unanimous": null
},
"conversion": null,
"detected_kind": "other",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0678.963.277",
"name": "Miracor Medical",
"role": "other",
"address": "Rue de Bruxelles 174, 4340 Awans",
"is_foreign": false,
"legal_form": "SA",
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": null,
"legal_articles": [
"582",
"583",
"596",
"612"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": 6235761,
"real_estate_included": false,
"patrimony_description": "L\u0027op\u00E9ration consiste en l\u0027\u00E9mission de 6 235 761 warrants donnant droit \u00E0 la souscription d\u0027une action de cat\u00E9gorie A, et en une augmentation de capital conditionnelle \u00E0 l\u0027exercice de ces warrants. Le capital est augment\u00E9 par cr\u00E9ation d\u0027une nouvelle action de cat\u00E9gorie A par warrant exerc\u00E9.",
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0678.963.277",
"name_full": "Miracor Medical",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Peter VAN MELKEBEKE",
"org_rep_person_name": null
},
"summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de Miracor Medical, r\u00E9unie le 4 mai 2018 \u00E0 Bruxelles, a d\u00E9cid\u00E9 d\u0027\u00E9mettre 6 235 761 warrants donnant droit \u00E0 la souscription d\u0027une action de cat\u00E9gorie A, sous r\u00E9serve de l\u0027attribution effective par le conseil d\u0027administration. Elle a \u00E9galement approuv\u00E9 l\u0027augmentation du capital social, conditionnelle \u00E0 l\u0027exercice des warrants, avec cr\u00E9ation d\u0027une nouvelle action de cat\u00E9gorie A par warrant exerc\u00E9. Le plan de warrants 2018, approuv\u00E9 par le conseil d\u0027administration, est annex\u00E9 au proc\u00E8s-verbal.",
"co_filed_documents": [
"une exp\u00E9dition de l\u0027acte",
"le Plan de Warrants de Mars 2018",
"la liste de pr\u00E9sence",
"le rapport du conseil d\u0027administration \u00E9tabli conform\u00E9ment \u00E0 l\u0027article 583 du Code des soci\u00E9t\u00E9s relatif \u00E0 l\u0027\u00E9mission de warrants",
"le rapport \u00E9tabli par le commissaire en application de l\u0027article 582 du Code des soci\u00E9t\u00E9s : Emission de droits de souscription \u00E0 un prix potentiellement inf\u00E9rieur au pair comptable des actions existantes",
"le rapport du commissaire sur la suppression du droit de pr\u00E9f\u00E9rence dans le cadre de l\u0027\u00E9mission de warrants",
"le rapport \u00E9tabli par le commissaire conform\u00E9ment \u00E0 l\u0027article 43, \u00A74 de la loi du 26 mars 1999 relative au plan belge pour l\u0027emploi 1998 et portant des dispositions diverses relatif \u00E0 l\u0027\u00E9mission des Warrants",
"le texte coordonn\u00E9 des statuts"
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": "capital_shares"
}08-02-2018 2 bestuurders benoemd
- Olivier Delporte — Gedelegeerd bestuurder
- Bertrand Grimmonpré — Représentant de b&o associates sprl
Technische details
{
"events": [
{
"kind": "director_in",
"role": "administrateur d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Olivier Delporte",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "repr\u00E9sentant de B\u0026O Associates SPRL",
"person": {
"rrn": null,
"name": "Bertrand Grimmonpr\u00E9",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0678.963.277",
"name_full": "Miracor Medical"
}
}22-01-2018 Publicatie in het Belgisch Staatsblad — Diversen
Technische details
{
"stage": null,
"notary": {
"name": "Peter VAN MELKEBEKE",
"firm_city": null,
"firm_name": "Berquin Notaires",
"office_city": "Bruxelles",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2018-01-22",
"filing_date": "2017-09-20",
"act_kind_objet": "CONSTATATION DE LA REALISATION DE LA FUSION TRANSFRONTALIERE"
},
"decision": {
"body": "bijzondere_algemene_vergadering",
"act_date": "2017-12-27",
"unanimous": null
},
"conversion": null,
"detected_kind": "other",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0678.963.277",
"name": "Miracor Medical",
"role": "acquiring",
"address": "rue des Berg\u00E8res 2, 1331 Rosi\u00E8res",
"is_foreign": false,
"legal_form": "soci\u00E9t\u00E9 anonyme",
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": null,
"name": "MIRACOR Medical Systems GmbH",
"role": "absorbed",
"address": "1060 Vienne (Autriche), Gumpendorferstrasse 139/5",
"is_foreign": true,
"legal_form": "soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
"is_new_company": false,
"jurisdiction_country": "AT"
}
],
"exchange_ratio": null,
"legal_articles": [
"772/6",
"772/8",
"772/9 \u00A73",
"602, \u00A71",
"12:7",
"12:50",
"12:75",
"12:103"
],
"is_cross_border": true,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": 54279180,
"real_estate_included": false,
"patrimony_description": "Le patrimoine entier de la soci\u00E9t\u00E9 absorb\u00E9e, sans exception ni r\u00E9serve, est transf\u00E9r\u00E9 \u00E0 titre universel \u00E0 la soci\u00E9t\u00E9 absorbante.",
"equity_transferred_eur": 542791.8,
"accounting_effective_date": "2017-07-31"
},
"subject_company": {
"kbo": "0678.963.277",
"name_full": "Miracor Medical",
"legal_form": "soci\u00E9t\u00E9 anonyme"
},
"detected_kind_raw": "fusion par absorption",
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Peter VAN MELKEBEKE",
"org_rep_person_name": null
},
"summary_narrative": "Le 27 d\u00E9cembre 2017, l\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de Miracor Medical, soci\u00E9t\u00E9 anonyme belge, a approuv\u00E9 la fusion transfrontali\u00E8re par absorption de MIRACOR Medical Systems GmbH, soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e autrichienne. La fusion est r\u00E9troactive \u00E0 compter du 31 juillet 2017, pour les fins comptables, fiscales et juridiques. Le capital social de Miracor Medical a \u00E9t\u00E9 augment\u00E9 de 542.791,80 \u20AC pour atteindre 604.291,80 \u20AC, par cr\u00E9ation de 54.279.180 nouvelles actions.",
"co_filed_documents": [
"une exp\u00E9dition de l\u0027acte"
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": null
}22-01-2018 Zetelverplaatsing van Rosières naar Awans
- Rue des Bergères 2, 1331 Rosières → < E40 Business Park », Chaussée de Bruxelles 174 à 4340 Awans
Technische details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "\u003C E40 Business Park \u00BB, Chauss\u00E9e de Bruxelles 174 \u00E0 4340 Awans",
"city": "Awans",
"region": "waals_gewest",
"street": "Chauss\u00E9e de Bruxelles",
"country": "BE",
"postcode": "4340",
"box_number": null,
"street_number": "174",
"locality_suffix": null
},
"old_address": {
"raw": "Rue des Berg\u00E8res 2, 1331 Rosi\u00E8res",
"city": "Rosi\u00E8res",
"region": "waals_gewest",
"street": "Rue des Berg\u00E8res",
"country": "BE",
"postcode": "1331",
"box_number": null,
"street_number": "2",
"locality_suffix": null
},
"effective_date": "2018-01-01",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de d\u00E9placer le si\u00E8ge social de la Soci\u00E9t\u00E9 de Rue des Berg\u00E8res 2 \u00E0 1331 Rosi\u00E8res vers \u003C E40 Business Park \u00BB, Chauss\u00E9e de Bruxelles 174 \u00E0 4340 Awans avec effet au 1er janvier 2018.",
"region_changed": false,
"is_statute_change": true,
"nationality_change": false,
"old_address_source": "header_volledig_adres",
"statute_clause_text": "Le si\u00E8ge est \u00E9tabli \u00E0 \u003C E40 Business Park \u00BB, Chauss\u00E9e de Bruxelles 174 \u00E0 4340 Awans.",
"statute_article_number": "2",
"effective_date_qualifier": "absolute",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": "Peter VAN MELKEBEKE",
"firm_city": null,
"firm_name": "Berquin Notaires",
"office_city": "Bruxelles",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2018-01-22",
"filing_date": "2017-09-20",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "bijzondere_algemene_vergadering",
"date": "2017-12-27",
"unanimous": true
},
"subject_company": {
"kbo": "0678.963.277",
"name_full": "Miracor Medical",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "org",
"org_kbo": "0686.820.871",
"org_name": "BDO R\u00E9viseurs d\u0027Entreprises Soc. Civ. S.C.R.L.",
"person_name": null,
"org_rep_person_name": "Dominique Milis",
"person_role_at_subject": null
},
"co_filed_documents": [
"Proc\u00E8s-verbal de l\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire",
"Rapport du r\u00E9viseur d\u0027entreprises (fusion transfrontali\u00E8re)",
"Rapport du r\u00E9viseur d\u0027entreprises (apport en nature)",
"Rapport du conseil d\u0027administration (warrants)",
"Texte coordonn\u00E9 des statuts",
"Rapport de l\u0027organe de gestion (article 772/8)",
"Rapport de l\u0027organe de gestion (article 560)",
"Vingt-cinq procurations"
]
}22-01-2018 Kapitaalverhoging van €269.567,90 tot €812.359,70
- €542.791,80 → €812.359,70
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 812359.7,
"delta_eur": 269567.8999999999,
"before_eur": 542791.8,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0678.963.277",
"name_full": "Miracor Medical"
}
}22-01-2018 Statutenwijziging
Technische details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": true
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0678.963.277",
"name_full": "Miracor Medical"
},
"legal_form_change": {
"new": "soci\u00E9t\u00E9 anonyme",
"old": "soci\u00E9t\u00E9 anonyme",
"changed": false
}
}22-01-2018 Publicatie in het Belgisch Staatsblad — Diversen
Technische details
{
"stage": "completed",
"notary": {
"name": "Peter VAN MELKEBEKE",
"firm_city": null,
"firm_name": "Berquin Notaires",
"office_city": "Bruxelles",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2018-01-22",
"filing_date": "2017-09-20",
"act_kind_objet": "FUSION TRANSFRONTALIERE PAR ABSORPTION DE \u0022MIRACOR MEDICAL"
},
"decision": {
"body": "algemene_vergadering",
"act_date": "2017-12-27",
"unanimous": true
},
"conversion": null,
"detected_kind": "merger_absorption",
"report_waiver": {
"summary": "L\u0027actionnaire unique de la soci\u00E9t\u00E9 Miracor Medical a renonc\u00E9 \u00E0 l\u0027examen du projet de fusion par un r\u00E9viseur d\u0027entreprises d\u00E9sign\u00E9 par la soci\u00E9t\u00E9 absorbante, conform\u00E9ment \u00E0 l\u0027article 772/9 \u00A73 du Code des soci\u00E9t\u00E9s belge.",
"articles": [
"772/9 \u00A73"
]
},
"restructuring": {
"parties": [
{
"kbo": "0678.963.277",
"name": "Miracor Medical",
"role": "acquiring",
"address": "Rue des Berg\u00E8res 2, 1331 Rosi\u00E8res",
"is_foreign": false,
"legal_form": "soci\u00E9t\u00E9 anonyme",
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": null,
"name": "MIRACOR Medical Systems GmbH",
"role": "absorbed",
"address": "1060 Vienne (Autriche), Gumpendorferstrasse 139/5",
"is_foreign": true,
"legal_form": "soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
"is_new_company": false,
"jurisdiction_country": "AT"
}
],
"exchange_ratio": 0.01,
"legal_articles": [
"772/6",
"772/14",
"772/9 \u00A73",
"772/1",
"772/14",
"12:7",
"12:50"
],
"is_cross_border": true,
"is_silent_merger": false,
"balance_basis_date": "2017-07-31",
"exchange_ratio_text": "1:100",
"new_shares_issued_n": 54279180,
"real_estate_included": false,
"patrimony_description": "La totalit\u00E9 du patrimoine de la soci\u00E9t\u00E9 absorb\u00E9e, sans exception ni r\u00E9serve, est transf\u00E9r\u00E9e \u00E0 titre universel \u00E0 la soci\u00E9t\u00E9 absorbante. L\u0027apport en nature comprend des cr\u00E9ances et un patrimoine actif et passif, dont la valeur nette est n\u00E9gative (-3.863.744,64 EUR), mais dont la valeur \u00E9conomique justifie la cr\u00E9ation de nouvelles actions.",
"equity_transferred_eur": -3863744.64,
"accounting_effective_date": "2017-07-31"
},
"subject_company": {
"kbo": "0678.963.277",
"name_full": "Miracor Medical",
"legal_form": "soci\u00E9t\u00E9 anonyme"
},
"publication_proxy": {
"kind": "org",
"org_kbo": "0686.820.871",
"org_name": "BDO R\u00E9viseurs d\u0027Entreprises Soc. Civ. S.C.R.L.",
"person_name": null,
"org_rep_person_name": "Dominique Milis"
},
"summary_narrative": "La soci\u00E9t\u00E9 anonyme Miracor Medical, ayant son si\u00E8ge \u00E0 Rosi\u00E8res, a d\u00E9cid\u00E9 de fusionner par absorption avec la soci\u00E9t\u00E9 autrichienne MIRACOR Medical Systems GmbH, dont le si\u00E8ge est \u00E0 Vienne. Cette fusion transfrontali\u00E8re a \u00E9t\u00E9 approuv\u00E9e par l\u0027actionnaire unique en assembl\u00E9e g\u00E9n\u00E9rale extraordinaire. La soci\u00E9t\u00E9 absorbante transf\u00E8re l\u0027ensemble du patrimoine de la soci\u00E9t\u00E9 absorb\u00E9e \u00E0 titre universel. Les actionnaires de la soci\u00E9t\u00E9 absorb\u00E9e re\u00E7oivent 54.279.180 nouvelles actions de cat\u00E9gorie A, B et C, selon un rapport d\u0027\u00E9change de 1:100. L\u0027op\u00E9ration est bas\u00E9e sur un bilan arr\u00EAt\u00E9 au 31 juillet 2017, et",
"co_filed_documents": [
"rapport de l\u0027organe de gestion \u00E9tabli conform\u00E9ment \u00E0 l\u0027article 772/8 du Code des soci\u00E9t\u00E9s",
"rapport de l\u0027organe de gestion et le rapport du r\u00E9viseur d\u0027entreprises \u00E9tabli conform\u00E9ment \u00E0 l\u0027article 602 du Code des soci\u00E9t\u00E9s (fusion transfrontali\u00E8re)",
"rapport de l\u0027organe de gestion et le rapport du r\u00E9viseur d\u0027entreprises \u00E9tabli conform\u00E9ment \u00E0 l\u0027article 602 du Code des soci\u00E9t\u00E9s (apport en nature)",
"rapport de l\u0027organe de gestion et le rapport du r\u00E9viseur d\u0027entreprises \u00E9tabli conform\u00E9ment aux articles 582 et 583 du Code des soci\u00E9t\u00E9s",
"texte coordonn\u00E9 des statuts",
"proc\u00E8s-verbal",
"vingt-cinq procurations"
],
"detected_real_type": "fusion_completed",
"referenced_correction": null,
"should_reroute_to_category": null
}02-10-2017 Publicatie in het Belgisch Staatsblad — Diversen
Technische details
{
"stage": "proposal",
"notary": {
"name": "Eric Spruyt",
"firm_city": null,
"firm_name": null,
"office_city": "Brussels",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2017-10-02",
"filing_date": "2017-09-20",
"act_kind_objet": "D\u00E9p\u00F4t d\u0027un projet de fusion par absorption transfrontali\u00E8re de Miracor"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2017-09-18",
"unanimous": null
},
"conversion": null,
"detected_kind": "merger_absorption",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": null,
"name": "Miracor Medical Systems GmbH",
"role": "absorbed",
"address": "Gumpendorferstra\u00DFe 139/5, 1090 Vienne, Autriche",
"is_foreign": true,
"legal_form": "GmbH",
"is_new_company": false,
"jurisdiction_country": "AT"
},
{
"kbo": "0678.963.277",
"name": "Miracor Medical SA",
"role": "acquiring",
"address": "Rue des Berg\u00E8res 2, 1331 Rosi\u00E8res",
"is_foreign": false,
"legal_form": "SA",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": 0.01,
"legal_articles": [
"12:7",
"12:50",
"772/6",
"772/14",
"12:75"
],
"is_cross_border": true,
"is_silent_merger": false,
"balance_basis_date": "2017-07-31",
"exchange_ratio_text": "1 action de la Soci\u00E9t\u00E9 Absorbante pour 100 unit\u00E9s de valeur nominale du capital social de la Soci\u00E9t\u00E9 Absorb\u00E9e",
"new_shares_issued_n": 61500,
"real_estate_included": false,
"patrimony_description": "L\u0027ensemble des actifs et passifs de la Soci\u00E9t\u00E9 Absorb\u00E9e, y compris ses activit\u00E9s de recherche, d\u00E9veloppement et commercialisation de technologies m\u00E9dicales, seront transf\u00E9r\u00E9s \u00E0 la Soci\u00E9t\u00E9 Absorbante. Le transfert concerne le patrimoine global, y compris les brevets, les droits de propri\u00E9t\u00E9 intellectuelle et les actifs immat\u00E9riels.",
"equity_transferred_eur": 542791.8,
"accounting_effective_date": "2017-07-31"
},
"subject_company": {
"kbo": "0678.963.277",
"name_full": "Miracor Medical SA",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "Laga",
"person_name": null,
"org_rep_person_name": "Anne Tilleux"
},
"summary_narrative": "Ce document est un projet de fusion par absorption transfrontali\u00E8re entre Miracor Medical Systems GmbH (Autriche) et Miracor Medical SA (Belgique). La Soci\u00E9t\u00E9 Absorb\u00E9e sera dissoute sans liquidation, et tous ses actifs et passifs seront transf\u00E9r\u00E9s \u00E0 la Soci\u00E9t\u00E9 Absorbante, qui continuera l\u0027activit\u00E9. Le rapport d\u0027\u00E9change est de 1:100, et les actions de la Soci\u00E9t\u00E9 Absorbante seront annul\u00E9es apr\u00E8s la fusion. L\u0027op\u00E9ration est soumise \u00E0 l\u0027approbation des assembl\u00E9es g\u00E9n\u00E9rales des actionnaires des deux soci\u00E9t\u00E9s.",
"co_filed_documents": [
"Exemplaire original du projet de fusion"
],
"detected_real_type": "fusion_proposal",
"referenced_correction": null,
"should_reroute_to_category": null
}01-08-2017 Oprichting van een SA
Technische details
{
"notary": {
"name": "Eric SPRUYT",
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2017-08-01",
"filing_date": "2017-07-28",
"act_kind_objet": "Objet de l\u0027acte:",
"is_private_deed": false
},
"decision": {
"body": "notarieel_alleen",
"act_date": "2017-07-28",
"unanimous": true
},
"founders": [
{
"org": {
"kbo": null,
"name": "Miracor Medical Systems GmbH",
"address": "1060 Wien (Autriche), Gumpendorferstrasse 139/5",
"country": "AT",
"legal_form": "Soci\u00E9t\u00E9 de droit autrichien",
"foreign_register_name": null,
"foreign_register_number": null
},
"kind": "rechtspersoon",
"person": null,
"share_class": null,
"partner_role": null,
"contribution_type": "geld",
"amount_paid_in_eur": 61499.0,
"is_subscriber_only": false,
"n_shares_subscribed": 61499,
"amount_subscribed_eur": 61499.0,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "DELPORTE Olivier Albert Marie Ghislain",
"niss": null,
"address": "3090 Overijse, Kapucijnendreef 62",
"nationality": null,
"place_of_birth": null
},
"share_class": null,
"partner_role": null,
"contribution_type": "geld",
"amount_paid_in_eur": 1.0,
"is_subscriber_only": false,
"n_shares_subscribed": 1,
"amount_subscribed_eur": 1.0,
"is_anonymous_silent_partner": false
}
],
"voorwerp": {
"full_text": "La soci\u00E9t\u00E9 a pour objet, en Belgique et \u00E0 l\u0027\u00E9tranger, pour son compte et pour le compte de tiers:\n(i) la conception, le d\u00E9veloppement, la mise au point, la fabrication et la commercialisation de diff\u00E9rents types de produits et de technologies medico-techniques (hardware et software);\n(ii) la planification et la r\u00E9alisation en interne ou avec des partenaires d\u0027\u00E9tudes de faisabilit\u00E9, d\u0027\u00E9tudes pr\u00E9cliniques, d\u0027\u00E9tudes cliniques et de tous tests et \u00E9tudes n\u00E9cessaires \u00E0 la r\u00E9alisation des \u00E9tapes pr\u00E9vues au point pr\u00E9c\u00E9dent;\n(iii) la formation, l\u0027entretien, la maintenance, la r\u00E9paration et le support \u00E0 l\u0027utilisation des dits produits m\u00E9dico-techniques;\n(iv) l\u0027analyse acad\u00E9mique de l\u0027utilisation de tels produits;\n(v) l\u0027\u00E9tablissement et l\u0027exploitation de toute propri\u00E9t\u00E9 intellectuelle et autres droits apparent\u00E9s en rapport avec des produits m\u00E9dico-techniques;\n(vi) l\u0027acquisition / la cession de parts / d\u0027entreprises / de technologies / de propri\u00E9t\u00E9 intellectuelle et autres droits assimil\u00E9s, en lien direct ou indirect avec les technologies medico-techniques.\nElle pourra s\u0027int\u00E9resser \u00E0 tous les d\u00E9veloppements technologiques et scientifiques li\u00E9s directement ou indirectement \u00E0 ses activit\u00E9s principales.\nElle a \u00E9galement pour objet exclusivement en son propre nom et pour son propre compte: faire des emprunts et consentir des pr\u00EAts, cr\u00E9dits, financements et la n\u00E9gociation de contrats de leasing, dans le cadre des buts d\u00E9crits ci-dessus.\nA cet effet, la soci\u00E9t\u00E9 peut collaborer et prendre part, ou prendre un int\u00E9r\u00EAt dans d\u0027autres entreprises, directement ou indirectement, de quelque mani\u00E8re que ce soit.\nLa soci\u00E9t\u00E9 peut d\u0027une fa\u00E7on g\u00E9n\u00E9rale accomplir toutes op\u00E9rations commerciales, industrielles, financi\u00E8res et mobili\u00E8res se rapportant directement ou indirectement \u00E0 son objet social ou qui seraient de nature \u00E0 en faciliter la r\u00E9alisation.",
"is_lucrative": true,
"short_summary": "Conception, d\u00E9veloppement, fabrication, commercialisation, maintenance et support de produits et technologies medico-techniques, ainsi que gestion de propri\u00E9t\u00E9 intellectuelle et financement."
},
"governance": {
"organ_kind": "raad_van_bestuur",
"n_directors_max": null,
"n_directors_min": 3,
"representation_clause": "deux administrateurs agissant conjointement",
"co_signature_threshold_eur": null
},
"fiscal_year": {
"end_mm_dd": "12-31",
"start_mm_dd": "01-01",
"first_exercise_end_date": "2018-12-31",
"is_prolonged_first_exercise": false
},
"agm_schedule": {
"time": "09:00",
"month": 5,
"rule_text": "premier mardi du mois de mai \u00E0 neuf (9) heures"
},
"founding_event": {
"n_shares_total": 61500,
"n_share_classes": 1,
"bank_attestation": {
"date": "2017-07-20",
"bank_name": "ING",
"amount_eur": 61500.0,
"iban_masked": "BE68 3630 6116 7634"
},
"amount_paid_in_eur": 61500.0,
"incorporation_date": "2017-07-28",
"amount_subscribed_eur": 61500.0,
"art_5_8_no_payment_due": false,
"pre_incorporation_activity_from_date": null
},
"subject_company": {
"kbo": "0678.963.277",
"email": null,
"region": "brussels_hoofdstedelijk_gewest",
"website": null,
"name_full": "Miracor Medical",
"legal_form": "SA",
"name_abbreviated": "Miracor Medical",
"zetel_address_raw": "1331 Rosi\u00E8res, Rue des Berg\u00E8res 2",
"equity_account_type": "unavailable"
},
"initial_directors": [
{
"kind": "rechtspersoon",
"person": null,
"via_org": {
"kbo": null,
"name": "B\u0026O Associates",
"legal_form": "BV"
},
"role_sub": "administrateur",
"mandate_until": {
"kind": "until_agm_year",
"value": 2023
},
"rep_person_name": "GRIMMONPR\u00C9 Bertrand Yvan Michel",
"additional_roles": [],
"bestuursverbod_checked": false,
"bestuursverbod_check_date": null,
"rep_prior_publication_ref": {
"date": "2017-08-01",
"numac_or_number": "17317825"
}
},
{
"kind": "rechtspersoon",
"person": null,
"via_org": {
"kbo": null,
"name": "ODMC",
"legal_form": "BV"
},
"role_sub": "administrateur",
"mandate_until": {
"kind": "until_agm_year",
"value": 2023
},
"rep_person_name": "DELPORTE Olivier",
"additional_roles": [],
"bestuursverbod_checked": false,
"bestuursverbod_check_date": null,
"rep_prior_publication_ref": {
"date": "2017-08-01",
"numac_or_number": "17317825"
}
}
],
"co_filed_documents": [
"expedition",
"statuten",
"volmacht",
"bankattest"
],
"post_incorporation_mandates": [
{
"kind": "volmacht_kbo",
"holder_org_kbo": null,
"holder_org_name": "Bertrand Grimmonpr\u00E9",
"with_substitution": true,
"holder_person_name": "Bertrand Grimmonpr\u00E9"
}
]
}Genereer een gestructureerde, feitelijke nota op basis van alle signalen in dit dossier: risico, financiële gezondheid, eigendomsstructuur, mandaten en sectorvergelijking.
| Officiële naamFR | Miracor Medical |